Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
5(50%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_4
1
10%
Ph early_phase_1
1
10%
Ph phase_2
4
40%
Ph phase_3
3
30%

Phase Distribution

1

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

10

all time

Status Distribution
Active(5)
Completed(5)

Detailed Status

Completed5
Recruiting4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 24 (40.0%)
Phase 33 (30.0%)
Phase 41 (10.0%)
N/A1 (10.0%)

Trials by Status

completed550%
recruiting440%
active_not_recruiting110%

Recent Activity

5 active trials
Showing 5 of 10
recruitingphase_3

Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes

NCT07499817
completedphase_2

Role of Pentoxifylline and Celecoxib in Parkinsonism

NCT05962957
completedphase_2

Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis

NCT05558761
active_not_recruitingphase_3

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

NCT05284656
completednot_applicable

Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients

NCT06458465
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07499817Phase 3

Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes

Recruiting
NCT05962957Phase 2

Role of Pentoxifylline and Celecoxib in Parkinsonism

Completed
NCT05558761Phase 2

Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis

Completed
NCT05284656Phase 3

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

Active Not Recruiting
NCT06458465Not Applicable

Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients

Completed
NCT05575505Phase 2

Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.

Recruiting
NCT05637086Phase 2

Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy

Recruiting
NCT06421870Phase 3

Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients

Recruiting
NCT04910178Phase 4

Follow-up of NAFLD Patients With MRI-PDFF

Completed
NCT04417049Early Phase 1

Treatment of Bipolar Depression With Pentoxifylline

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10